West Tower Group’s Chemed CHE Stock Holding History

West Tower Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42	Closed	-$24.6K	–	165
2023 Q4	$24.6K	Buy	42 +11	+35%	+$6.16K	0.05%	271
2023 Q3	$16.1K	Buy	+31	New	+$16.1K	0.01%	342

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

West Tower Group's CHE Position: Q1 2024 in Review

West Tower Group sold out of Chemed (CHE) in Q1 2024, closing a stake of 42 shares — an estimated $24.6K sold.

West Tower Group first reported a position in CHE in Q3 2023 and held it in 2 quarters. The position peaked at $24.6K in Q4 2023. 511 funds tracked by Wall St. Rank hold CHE as of Q1 2024.

West Tower Group reported no remaining Chemed position as of Q1 2024 after selling out during the quarter.
West Tower Group sold 42 Chemed shares in Q1 2024, an estimated $24.6K.
West Tower Group first reported a position in Chemed in Q3 2023 and held it in 2 quarters.
West Tower Group's Chemed position peaked at $24.6K in Q4 2023.
511 funds tracked by Wall St. Rank held Chemed as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.